Microport Cardioflow Medtech Corp
HKEX:2160

Watchlist Manager
Microport Cardioflow Medtech Corp Logo
Microport Cardioflow Medtech Corp
HKEX:2160
Watchlist
Price: 0.87 HKD
Market Cap: 2.1B HKD

Operating Margin
Microport Cardioflow Medtech Corp

-44.1%
Current
-102%
Average
4%
Industry

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-44.1%
=
Operating Profit
-159.5m
/
Revenue
361.6m

Operating Margin Across Competitors

Microport Cardioflow Medtech Corp
Glance View

Market Cap
2.1B HKD
Industry
Health Care

MicroPort CardioFlow Medtech Corp. operates as a holding company with interest in developing medical devices. The company is headquartered in Shanghai, Shanghai. The company went IPO on 2021-02-04. The firm is mainly engaged in the development and commercialization of transcatheter and surgical solutions for valvular heart diseases. The firm's main products include the first-generation transcatheter aortic heart valve implantation (TAVI) product VitaFlow and the second-generation TAVI product VitaFlow II. The firm mainly conducts business within the domestic market.

Intrinsic Value
1.71 HKD
Undervaluation 49%
Intrinsic Value
Price
What is Operating Margin?

Operating Margin represents how efficiently a company is able to generate profit through its core operations.

Higher ratios are generally better, illustrating the company is efficient in its operations and is good at turning sales into profits.

Operating Margin
-44.1%
=
Operating Profit
-159.5m
/
Revenue
361.6m
What is the Operating Margin of Microport Cardioflow Medtech Corp?

Based on Microport Cardioflow Medtech Corp's most recent financial statements, the company has Operating Margin of -44.1%.

Back to Top